You just read:

Daratumumab (DARZALEX®) Combination Therapy Significantly Extended Progression-Free Survival in Previously Treated Patients with Multiple Myeloma

News provided by

Janssen Research & Development, LLC

Jun 05, 2016, 07:35 ET